{"id":32422,"date":"2026-03-23T21:04:34","date_gmt":"2026-03-23T21:04:34","guid":{"rendered":"https:\/\/rhepa.se\/?page_id=32422"},"modified":"2026-05-19T08:08:41","modified_gmt":"2026-05-19T08:08:41","slug":"ny-fond-privat","status":"publish","type":"page","link":"https:\/\/rhepa.se\/en\/ny-fond-privat\/","title":{"rendered":"Next Generation"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

A fund at the frontier of healthcare<\/i><\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Important information: <\/b>The fund is for professional investors only. Please contact us by emailing info@rhepa.com for KIDs. <\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rhenman Healthcare Next Generation L\/S is a long biased hedge fund predominantly investing in micro-, small- and mid-cap companies. A fundamentally driven bottom-up approach, with emphasis on companies at the forefront of medical innovation and scientific advancement.<\/p>

\u00a0<\/p>

The investment team is supported by a Scientific Advisory Board dedicated to the fund.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tMeet the Scientific Advisory Board<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tComing soon: Fund performance <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Important:<\/strong> For investors in the fund. Past performance is not an guarantee of future returns.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Rhenman Healthcare Equity L\/S (RHE L\/S)\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
Rhenman Healthcare Equity L\/S (RHE L\/S)<\/div>
April 2026<\/div>
The fund performance is calculated and reported once a month.<\/div>
FUND CLASS<\/td>NAV<\/td>DEVELOPMENT 1 MONTH<\/td>THIS YEAR<\/td>SINCE FUND START<\/td>START DATE<\/td><\/tr><\/thead>
IC1 (EUR)<\/td>853.09<\/td>-0.52%<\/td>-12.70%<\/td>753.09%<\/td>2009-06-22<\/td><\/tr>
IC3 (EUR)<\/td>1110.92<\/td>-0.46%<\/td>-12.48%<\/td>1010.92%<\/td>2009-07-31<\/td><\/tr>
IC2 (SEK)<\/td>676.17<\/td>-1.64%<\/td>-12.30%<\/td>576.17%<\/td>2012-12-31<\/td><\/tr>
ID1 (SEK)Distributing<\/td>352.15<\/td>-1.69%<\/td>-16.17%<\/td>252.15%<\/td>2012-04-30<\/td><\/tr>
IC1 (USD)<\/td>225.96<\/td>1.24%<\/td>-12.81%<\/td>125.96%<\/td>2015-01-31<\/td><\/tr>
RC1 (EUR)<\/td>720.80<\/td>-0.57%<\/td>-12.85%<\/td>620.80%<\/td>2010-08-31<\/td><\/tr>
RC1 (SEK)<\/td>767.71<\/td>-1.73%<\/td>-12.60%<\/td>667.71%<\/td>2009-06-22<\/td><\/tr>
RC2 (SEK)<\/td>826.52<\/td>-1.69%<\/td>-12.45%<\/td>726.52%<\/td>2009-06-22<\/td><\/tr><\/tbody><\/table><\/div><\/div>\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Important information: <\/strong>Past performance is no guarantee of future returns. The money invested in the fund can both increase and decrease in value and it is not certain that investors will get back the entire invested capital.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t